Planet 13 Holdings (PLNH) Cash & Current Investments (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Cash & Current Investments came in at $16.3 million in Q1 2026, down 7.67% year-on-year from $17.6 million in Q1 2025, and up 4.38% on a QoQ basis from $15.6 million in Q4 2025.
Planet 13 Holdings (PLNH) Cash & Current Investments (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Cash & Current Investments data on file, last reported at $16.3 million in Q1 2026.
- On a quarterly basis, Cash & Current Investments fell 7.67% year-over-year to $16.3 million in Q1 2026; TTM through Mar 2026 was $16.3 million, a 7.67% decrease from a year earlier, with the FY2025 full-year figure at $15.6 million, down 38.77% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $16.3 million, up from $15.6 million in the prior quarter.
- Over the last five years, Cash & Current Investments for PLNH reached as high as $62.1 million in Q1 2022 and fell as low as $15.6 million in Q4 2025.
- Historically, Cash & Current Investments has averaged $28.4 million across 5 years, with a median of $24.5 million in 2023.
- On a YoY basis, Cash & Current Investments climbed as much as 37349.39% in 2022 and fell as far as 61.39% in 2022.
- Year by year, Cash & Current Investments stood at $38.8 million in 2022, then tumbled by 55.45% to $17.3 million in 2023, then surged by 47.18% to $25.4 million in 2024, then sank by 38.77% to $15.6 million in 2025, then increased by 4.38% to $16.3 million in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $16.3 million in Q1 2026, $15.6 million in Q4 2025, and $17.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 3.74 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 1.94 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 4.06 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 2.15 Bn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 1.80 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.32 Bn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 428.00 Mn |
| 10 | Planet 13 Holdings | 39.42 Mn | 23.16 Mn | 9.41 Mn | 16.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.26 Mn |
| Dec 31, 2025 | 15.58 Mn |
| Sep 30, 2025 | 17.18 Mn |
| Jun 30, 2025 | 15.85 Mn |
| Mar 31, 2025 | 17.61 Mn |
| Dec 31, 2024 | 25.44 Mn |
| Sep 30, 2024 | 29.46 Mn |
| Jun 30, 2024 | 28.72 Mn |
| Mar 31, 2024 | 22.82 Mn |
| Dec 31, 2023 | 17.28 Mn |
| Sep 30, 2023 | 20.49 Mn |
| Jun 30, 2023 | 24.46 Mn |
| Mar 31, 2023 | 26.92 Mn |
| Dec 31, 2022 | 38.79 Mn |
| Sep 30, 2022 | 50.88 Mn |
| Jun 30, 2022 | 52.62 Mn |
| Mar 31, 2022 | 62.14 Mn |
| Dec 31, 2021 | 58.59 Mn |
| Sep 30, 2021 | 1.62 Mn |
| Jun 30, 2021 | 136.29 Mn |